Authors: Fountzilas, G Tsavdaridis, D Kalogera-Fountzila, A Christodoulou, C Timotheadou, E Kalofonos, C Kosmidis, P Adamou, A Papakostas, P Gogas, H Stathopoulos, G Razis, E Bafaloukos, D Skarlos, D

Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551

Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM

Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220

Authors: Fountzilas, G Stathopoulos, G Nicolaides, C Kalogera-Fountzila, A Kalofonos, H Nikolaou, A Bacoyiannis, C Samantas, E Papadimitriou, C Kosmidis, P Daniilidis, J Pavlidis, N

Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478

Authors: Malamitsi, J Stathopoulos, G Kittas, C Chorti, M Colialexi, A Hadziyannis, S Proukakis, C

Citation: J. Malamitsi et al., Diagnostic value of anti-alpha FP antibody levels in a metastatic germ cell tumor of unknown primary site, ANTICANC R, 19(3B), 1999, pp. 2201-2204